| Cathy Denise Moynihan, DNP-FNP-BC-CDE | |
|
14680 S La Grange Rd, Orland Park, IL 60462-2510 | |
| (800) 323-8622 | |
| (224) 225-0375 |
| Full Name | Cathy Denise Moynihan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 23 Years |
| Location | 14680 S La Grange Rd, Orland Park, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154478832 | NPI | - | NPPES |
| 209004308 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 209004308 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health will offer free training and technical assistance for organizations that seek to use the Guided Care model to participate in the Medicare Shared Savings Program.
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
The reality of life in the operating room is about to look more like virtual reality, as leaders in clinical medicine at the University of Maryland, Baltimore and colleagues with expertise in computing and imaging at the University of Maryland, College Park work together on lifesaving technologies.
› Verified 9 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health will offer free training and technical assistance for organizations that seek to use the Guided Care model to participate in the Medicare Shared Savings Program.
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
The reality of life in the operating room is about to look more like virtual reality, as leaders in clinical medicine at the University of Maryland, Baltimore and colleagues with expertise in computing and imaging at the University of Maryland, College Park work together on lifesaving technologies.
› Verified 9 days ago
| Entity Name | Marlin C Hoover Phd Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871578625 PECOS PAC ID: 9335136696 Enrollment ID: O20040428000892 |
News Archive
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health will offer free training and technical assistance for organizations that seek to use the Guided Care model to participate in the Medicare Shared Savings Program.
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
The reality of life in the operating room is about to look more like virtual reality, as leaders in clinical medicine at the University of Maryland, Baltimore and colleagues with expertise in computing and imaging at the University of Maryland, College Park work together on lifesaving technologies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cathy Denise Moynihan, DNP-FNP-BC-CDE 29373 Network Pl, Chicago, IL 60673-1293 Ph: (847) 390-5900 | Cathy Denise Moynihan, DNP-FNP-BC-CDE 14680 S La Grange Rd, Orland Park, IL 60462-2510 Ph: (800) 323-8622 |
News Archive
The Roger C. Lipitz Center for Integrated Health Care at the Johns Hopkins Bloomberg School of Public Health will offer free training and technical assistance for organizations that seek to use the Guided Care model to participate in the Medicare Shared Savings Program.
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
The reality of life in the operating room is about to look more like virtual reality, as leaders in clinical medicine at the University of Maryland, Baltimore and colleagues with expertise in computing and imaging at the University of Maryland, College Park work together on lifesaving technologies.
› Verified 9 days ago
Rachel Hesse, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 14290 S La Grange Rd, Orland Park, IL 60462 Phone: 866-389-2727 | |
Tasheia Lashay Williams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 15303 S 94th Ave., Suite 250, Orland Park, IL 60462 Phone: 630-428-7890 | |
Kay Budick, R.N., C.N.S. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 14400 John Humphrey Dr, Suite 200, Orland Park, IL 60462 Phone: 708-675-1305 Fax: 708-226-1657 | |
Gail Scruggs Lauryn, A.P.N. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10745 165th St, Orland Park, IL 60467 Phone: 708-799-8384 Fax: 708-799-1305 | |
Stella Lewally, AGPCNP-BC, RN-BSN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11528 183rd St, Orland Park, IL 60467 Phone: 919-349-3467 | |
Amanda Erdmann, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 14290 S La Grange Rd, Orland Park, IL 60462 Phone: 708-403-2356 | |
Dr. Keith Jerome Carter, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14300 S Ravinia Ave Ste 100, Orland Park, IL 60462 Phone: 630-974-6602 Fax: 630-487-2411 |